Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cocrystal Pharma stock | $0.9582

Learn how to easily invest in Cocrystal Pharma stock.

Cocrystal Pharma Inc is a biotechnology business based in the US. Cocrystal Pharma shares (COCP) are listed on the NASDAQ and all prices are listed in US Dollars. Cocrystal Pharma employs 13 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Cocrystal Pharma

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – COCP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cocrystal Pharma stock price (NASDAQ: COCP)

Use our graph to track the performance of COCP stocks over time.

Cocrystal Pharma shares at a glance

Information last updated 2021-10-16.
Latest market close$0.96
52-week range$0.76 - $2.37
50-day moving average $1.05
200-day moving average $1.17
Wall St. target price$4.33
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.15

Buy Cocrystal Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cocrystal Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cocrystal Pharma price performance over time

Historical closes compared with the close of $0.9582 from 2021-10-22

1 week (2021-10-15) 1.90%
1 month (2021-09-23) -9.60%
3 months (2021-07-23) -15.95%
6 months (2021-04-23) -23.95%
1 year (2020-10-23) 11.41%
2 years (2019-10-23) -16.68%
3 years (2018-10-23) 2.6
5 years (2016-10-21) 93.77%

Cocrystal Pharma financials

Revenue TTM $999,000
Gross profit TTM $-4,293,000
Return on assets TTM -10.5%
Return on equity TTM -17.6%
Profit margin 0%
Book value $0.87
Market capitalisation $91.6 million

TTM: trailing 12 months

Shorting Cocrystal Pharma shares

There are currently 772,545 Cocrystal Pharma shares held short by investors – that's known as Cocrystal Pharma's "short interest". This figure is 13.7% down from 894,747 last month.

There are a few different ways that this level of interest in shorting Cocrystal Pharma shares can be evaluated.

Cocrystal Pharma's "short interest ratio" (SIR)

Cocrystal Pharma's "short interest ratio" (SIR) is the quantity of Cocrystal Pharma shares currently shorted divided by the average quantity of Cocrystal Pharma shares traded daily (recently around 977905.06329114). Cocrystal Pharma's SIR currently stands at 0.79. In other words for every 100,000 Cocrystal Pharma shares traded daily on the market, roughly 790 shares are currently held short.

However Cocrystal Pharma's short interest can also be evaluated against the total number of Cocrystal Pharma shares, or, against the total number of tradable Cocrystal Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cocrystal Pharma's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Cocrystal Pharma shares in existence, roughly 10 shares are currently held short) or 0.0111% of the tradable shares (for every 100,000 tradable Cocrystal Pharma shares, roughly 11 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cocrystal Pharma.

Find out more about how you can short Cocrystal Pharma stock.

Cocrystal Pharma share dividends

We're not expecting Cocrystal Pharma to pay a dividend over the next 12 months.

Have Cocrystal Pharma's shares ever split?

Cocrystal Pharma's shares were split on a 1:30 basis on 23 January 2018. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cocrystal Pharma shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Cocrystal Pharma shares which in turn could have impacted Cocrystal Pharma's share price.

Cocrystal Pharma share price volatility

Over the last 12 months, Cocrystal Pharma's shares have ranged in value from as little as $0.76 up to $2.37. A popular way to gauge a stock's volatility is its "beta".

COCP.US volatility(beta: 0.78)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cocrystal Pharma's is 0.7831. This would suggest that Cocrystal Pharma's shares are less volatile than average (for this exchange).

Cocrystal Pharma overview

Cocrystal Pharma, Inc. , a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase 2a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp.

Frequently asked questions

What percentage of Cocrystal Pharma is owned by insiders or institutions?
Currently 17.836% of Cocrystal Pharma shares are held by insiders and 27.209% by institutions.
How many people work for Cocrystal Pharma?
Latest data suggests 13 work at Cocrystal Pharma.
When does the fiscal year end for Cocrystal Pharma?
Cocrystal Pharma's fiscal year ends in December.
Where is Cocrystal Pharma based?
Cocrystal Pharma's address is: 19805 North Creek Parkway, Bothell, WA, United States, 98011
What is Cocrystal Pharma's ISIN number?
Cocrystal Pharma's international securities identification number is: US19188J3005
What is Cocrystal Pharma's CUSIP number?
Cocrystal Pharma's Committee on Uniform Securities Identification Procedures number is: 09072E103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site